The UK Israel HealthTech Forum connects leading UK health professionals, NHS technology and innovation leaders, academic health networks and local investors with Israel’s top HealthTech leaders and companies.
In a series of briefings in the UK, participants will enjoy the opportunity to hear and engage with both established companies & entrepreneurs and the most promising startups in the HealthTech space.
Israel is renowned as the ‘Silicon Valley for the rest of the world’, backed by world-class university research. In recent years, Israeli expertise in both technology and sciences have converged to produce world-leading digital health companies, supported by a highly educated and uniquely qualified workforce, backed by supportive government initiatives and venture capital.
Elad is a Chief Business Development Officer at Operose Health (formerly Ceneten UK), the UK arm of Centene Corp, a FORTUNE® 100, supporting and enabling integrated care in the UK
Elad has 20 years of experience in senior leadership roles in global sales, marketing, business development and general management within the healthcare industry spanning pharma, biotech, medical device, and digital health markets.
Previously Elad was the CEO of Connected HealthTech Solutions (CHS), the UK subsidiary of Femi Health, Israel’s largest independent healthcare provider and operators of one of the world’s leading telemedicine platforms serving PMIs, HMOs and the Israeli MoH.
Prior to CHS, Elad was the Global Chief Marketing Officer and subsequently the President of AposTherapy UK, a novel MedTech platform in orthopaedics and MSK where he led the successful introduction and adoption of the product by the NHS and private markets. Previously Elad was the Marketing and BD Director at Se-Cure Pharmaceuticals, an Israeli innovative biotechnology company in Women’s Health & Osteoporosis. Prior to that, Elad led the European healthcare practice of Harris Interactive Inc., a major global marketing research firm advising various leading medical device and pharmaceutical companies.
Elad holds an Executive MBA in Marketing and Management from the Hebrew University in Jerusalem, and a bachelor’s degree in Business and International Marketing from the Institute Superior de Gestion in Paris, France.
Ian has been a practising GP in Hillingdon for over 30 years and a GP trainer for over 25 years. He has been the Chair of the NHS Hillingdon CCG since April 2011 and has been actively engaging Hillingdon’s 45 practices through the change to clinical commissioning. Ian takes a key role in driving change and innovation in General Practice and has been involved in various commissioning projects since 1990.
Dr Claire Lemer combines working as a paediatric consultant with medical management and service transformation.
Claire spent two and a half years at the Department of Health and World Health Organisation where she worked in public health, quality improvement and developing clinical leadership programmes.
During 2004-2005, Claire was a Harkness Fellow in Health Policy, in Boston, USA, where she researched the effects of communication in paediatric medication safety.
She has co-authored two books on medical management.
Ravit is a partner at Kamet – A startup studio, funded by AXA that invents, incubates, builds and scales companies in Digital Health and Insure-tech. She is leading the healthcare activities out of their Tel-Aviv office.
In her previous role, Ravit was head of Innovation for National Digital Health at the Israeli Ministry of Health, where she built models for the integration of digital health solutions into healthcare organisations.
Ravit has been active in the Digital Health space in the UK and Israel from 2010. Her experience includes co-founding a bio-feedback startup, serving as a healthcare consultant for multinational corporations and heading Product Management, Innovation and Business Development for Digital Health, AI and Digital Science companies. Ravit is also one of the first organizers of mHealth Israel – the largest digital health community in Israel.
Prior to her career in Digital Health, Ravit spent 10 years in Israeli high-tech, across different industries and a range of positions including Business Development, Product Management, R&D Management and Engineering.
Ravit is a graduate of an elite technology unit in the IDF and has a B.Sc. in Bioinformatics from Tel-Aviv University and an MBA from Judge Business School in Cambridge (UK)
Gil is currently a Senior Commercial Manager with Boston Scientific in their Healthcare Solutions & Partnerships organisation, which he joined to establish 6 years ago. Since then he has been leading the development of innovative “beyond the device” agreements with key hospitals throughout Europe, addressing a range of strategic and operational challenges they face, with solutions that span financial, consultative and digital capabilities.
Gil brings 15 years business experience across operations management, corporate strategy, marketing and sales. He has extensive experience designing and deploying novel contracting and payment models that support a “value-based” agenda: working with NHS and other healthcare bodies in the EU and Nordics, to develop commercial frameworks that stimulate enhanced clinical outcomes or deliver systemic cost savings. Gil also leads Boston Scientific’s strategic initiatives group on value-based healthcare for the EMEA region.
A British-Israeli dual-national based in London, Gil engages closely with the UK and European HealthTech market, whilst maintaining an enduring connection to the Israeli innovation ecosystem. He continues to forge meaningful associations with technology ventures and investor communities, with a view to better align data-driven healthcare innovations with relevant opportunities. A keen believer in the potential for digital tools that enable clinical pathway optimisation for chronic disease-states, Gil recently drove the successful introduction of a Heart Failure care management platform for the identification, engagement and coordination of target patients, at an acute tertiary Trust in north of England.
Prior to his career in HealthTech, Gil was a consultant at The Boston Consulting Group (BCG) working with clients across a range of sectors including technology, financial services, biopharma and public health. Earlier in his career, he spent a number of years at Procter & Gamble managing manufacturing operations as well as leading capital projects and new initiatives for some of P&G’s largest brands.
Gil holds an MBA from London Business School, where he was a Sainsbury Management Fellow and a Masters in Chemical Engineering from Imperial College, London.